Stereotaxis Announces CE Mark Submission for Robotically Navigated MAGiC Ablation Catheter
Building on over 100,000 procedures and nearly twenty years of experience gained from existing robotically navigated ablation catheters, MAGiC has been developed in collaboration with Osypka, a German medical devices company that pioneered the development of radiofrequency ablation of cardiac arrhythmias. MAGiC incorporates various features that are designed to enhance patient safety and efficacy, procedural efficiency, and the physician experience.
“The electrophysiology community has long awaited innovation in robotic catheter technology, and we are very excited by the near-term availability of the MAGiC catheter,” said Prof.
CE Mark submission of the MAGiC catheter reflects the culmination of an extensive design, development, manufacturing and testing effort. This catheter is the first in a series of interventional devices being developed by
“We are very pleased to reach this important milestone. This is a seminal event for
About
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe”, "estimate”, "project”, "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to manage expenses at sustainable levels, acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase its technology, competitive factors, changes resulting from healthcare policy, dependence upon third-party vendors, timing of regulatory approvals, the impact of pandemics or other disasters, and other risks discussed in the Company's periodic and other filings with the
Investor Contacts: | Media Contact: |
Chairman and Chief Executive Officer | Director, |
314-678-6213 | |
B.Schluter@Stereotaxis.com | |
Chief Financial Officer | |
314-678-6100 | |
Investors@Stereotaxis.com |
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/0601c262-27e0-4bed-a86e-36199cc54b55
https://www.globenewswire.com/NewsRoom/AttachmentNg/97cc4b8f-00b8-4f32-9652-3f83f778a412
Stereotaxis Robotically Navigated MAGiC Catheter for Cardiac Ablation
Stereotaxis has announced CE Mark submission for its novel, robotically navigated MAGiC ablation catheter for the treatment of cardiac arrhythmias. Design features include a round, solid gold tip with 25 irrigation ports and string-of-pearls distribution of magnetic material along the catheter’s flexible shaft.
Stereotaxis Robotic Magnetic Navigation System
Procedure room equipped with Stereotaxis Robotic Magnetic Navigation (RMN) system for minimally invasive endovascular intervention. Robotic cardiac ablation is performed using a soft magnetic catheter navigated inside the heart by a physician seated at a computer cockpit. The physician navigates the catheter using precise, robotically actuated magnets positioned on either side of the patient.
Source: Stereotaxis, Inc.